Myxedema coma
Myxedema coma is a rare, life-threatening decompensation of severe, longstanding hypothyroidism. Despite its name, patients are often not actually comatose. It is an ICU emergency.
Typical presentation
Think of the triad:
- Altered mental status: lethargy, confusion, stupor, or coma
- Hypothermia
- Hypoventilation/respiratory depression
Other findings include bradycardia, hypotension, hyponatremia, hypoglycemia, reduced reflexes, puffy/coarse skin, and sometimes pericardial effusion. It often follows a precipitating stressor in a patient with untreated or undertreated hypothyroidism.
ROSEN's Emergency Medicine, lines 348-351; Goodman & Gilman's Pharmacological Basis of Therapeutics, lines 2467-2471.
Common precipitants
- Infection, including pneumonia or UTI
- Stopping or missing levothyroxine
- Cold exposure
- Surgery, trauma, stroke, myocardial infarction, or heart failure
- Sedatives, opioids, anesthetics, or other CNS depressants
- GI bleeding or metabolic disturbance
Investigations
Do not delay treatment while waiting for results.
- TSH and free T4, often high TSH with very low free T4 in primary hypothyroidism
- Serum cortisol before steroids if this does not delay therapy
- Glucose, electrolytes, ABG/VBG, CBC, renal and liver tests
- ECG, chest imaging, cultures, and evaluation for infection/MI/stroke or another trigger
- Consider central hypothyroidism if TSH is low or inappropriately normal despite low free T4.
Immediate management
-
ICU care, ABCs
- Supplemental oxygen and early intubation/mechanical ventilation if hypoventilation, hypercapnia, or impaired airway protection.
- Cautious IV fluids and vasopressors if needed.
-
Give stress-dose glucocorticoids first
- Example: hydrocortisone 100 mg IV every 8 hours.
- Draw cortisol beforehand if feasible, but do not delay therapy. Steroids protect against unrecognized adrenal insufficiency, which thyroid-hormone treatment can unmask. ATA guideline recommendations
-
IV levothyroxine (T4)
- Loading: 200-400 micrograms IV once
- Then about 1.6 micrograms/kg/day, using roughly 75% of the equivalent oral dose while IV. Use a lower load/maintenance dose in older patients or those with coronary disease or arrhythmia. ATA/Endotext guidance
-
Consider IV liothyronine (T3) selectively
- May be added in severe cases or inadequate clinical response.
- A commonly cited regimen is 5-20 micrograms IV loading, then 2.5-10 micrograms IV every 8 hours.
- Avoid excessive doses because tachyarrhythmia and myocardial ischemia are concerns, especially in elderly or cardiac patients. ATA guideline recommendations
-
Supportive treatment
- Passive warming with blankets. Avoid aggressive peripheral active rewarming because vasodilation can worsen hypotension.
- Correct hypoglycemia with dextrose.
- Correct severe hyponatremia carefully.
- Identify and treat the trigger. Give empiric antibiotics when infection is suspected.
Monitoring
Monitor mental status, temperature, respiratory function/ABGs, ECG and cardiac status, blood pressure, glucose, fluid balance, sodium, and free T4/T3 every 1-2 days initially. TSH improves slowly and is not useful for immediate response assessment.
Key exam point
Sequence: ICU stabilization -> cortisol sample if feasible -> IV hydrocortisone -> IV levothyroxine -> treat precipitating cause and complications.
Published recommendations are based largely on expert consensus and case data because this condition is too rare for practical randomized trials. No recent systematic review/meta-analysis was found in the last 2 years.